Meridian Bioscience Inc.

NASDAQ:VIVO  
18.14
-0.41 (-2.21%)
Other Pre-Announcement

Meridian Bioscience Qtrly Adjusted EPS $0.19

Published: 11/13/2020 13:34 GMT
Meridian Bioscience Inc (VIVO) - Q4 Revenue Rose 26% to $64.2 Million .
Meridian Bioscience Reports Strong Fourth Quarter and Record Full-year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance.
Q4 Revenue Estimate $59.6 Million -- Refinitiv Ibes Data (analyst estimates).
Qtrly Earnings per Share $0.15.
Qtrly Adjusted Earnings per Share $0.19.
Sees Fiscal 2021 Consolidated Revenues – $290 Million to $310 Million.
Sees 2021 Adjusted Earnings per Share $1.14 to $1.28.